Protabit is a biotechnology startup that was founded in 2009. The company operates within the industries of Biotechnology, Health Care, Health and Wellness, and Life Sciences. The most recent investment of $1.00M came in the form of a grant at 28 June 2022 from the National Science Foundation. This funding is a testament to the potential that industry experts see in Protabit's innovative approach to biotechnology and its applications in the healthcare and life sciences sectors.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Grant | $1.00M | 1 |
|
28 Jun 2022 |
| Grant | $256.00K | 1 |
|
21 May 2020 |
| Grant | $750.00K | 1 |
|
14 Sep 2015 |
| Grant | $230.00K | 1 |
|
11 Dec 2013 |
| Grant | $225.00K | 1 |
|
01 Jul 2013 |
No recent news or press coverage available for Protabit.
We care about your data, and we'd love to use cookies make your experience better.
